Biosight was founded by Manus J. Donahue, PhD with the goal of improving the impact of clinical trials, and most importantly the lives of patients, by utilizing both the expertise of healthcare providers and quantitative scientists to take full advantage of the spectrum of theranostic care available today.

​

Manus was educated at Duke University (Physics: BS; Philosophy: BA), The Johns Hopkins University School of Medicine (Biophysics: PhD), and the University of Oxford (Clinical Neurology: fellowship).

​

He is currently a tenured member of the faculty at Vanderbilt University Medical Center in Nashville, TN where he is a member of the Departments of Neurology, Psychiatry, Physics, and Radiology, a senior member of the Vanderbilt Brain Institute, and voting member on the Vanderbilt Institutional Review Board (IRB) Heath Sciences Committee. He has published more than 100 peer-reviewed manuscripts, has research and development or consulting contracts with pharmaceutical and healthcare technology industry partners, has supported more than 20 foundation or government-funded studies as a funded co-investigator or consultant, and serves as an ad hoc member on multiple National Institutes of Health study sections.  

 

Biosight services comprise imaging technology implementation, data analysis, statistical trial design, and funding application preparation.